Shanghai INT Medical Instruments Co., Ltd. (hereinafter referred to as "our company") was established in 2006. Our company is a listed company on main board of Hong Kong Exchange (Stock name: INT Medical, stock code: HK1501).

We are a leading Chinese cardiovascular interventional device manufacturer with the complete industrial chain which consists of several competence including independent mold tooling, product R&D, equipment developing and sterilization. We have obtained ISO13485, CE and FDA certification. Our products export to over 70 countries and regions including the United States and Europe.

Currently, we own 16 subsidiaries and the business pipeline covers Cardiology, Neurology, ENT, Orthopedics, Urology, Regenerative Aesthetics and Focused Ultrasound Therapy. By the end of December 31, 2023, our company had obtained 73 NMPA certificates, 36 CE certificates, 18 FDA certificates and 334 authorized patents, 208 patents under application and 9 software copyrights.

We adhere to the corporate culture of "Team is the cornerstone of enterprise; Innovation is the engine of development; Execution is the key to success", and continuously enhance the ability of independent innovation and develops independent intellectual property products.  

We now have employed more than 1500 employees and our major plant is located in Jiading, Shanghai. In the future, our company will adhere to the development vision of "To be a world-renowned interventional and implantable medical device group led by scientific and technological innovation", continue to uphold the development concept of "Innovation serves health, high-quality achieves excellence", and contribute to the development of China's medical device industry and global human health!